In a major strategic shift for its theatrical distribution pipeline, Marvel Studios confirmed Thursday it will replace the signature post-credits sequence in its next tentpole with a straightforward commercial for ibuprofen. The move marks a stark departure from the studio’s long-standing tradition of teasing future cinematic installments to exhausted moviegoers.
According to sources familiar with the rollout, audiences staying through the final scroll of the upcoming Captain America: Brave New World will not see a surprise CGI cameo setting up a 2028 crossover event. Instead, the screen will cut to a casually dressed man rubbing his temples in a well-lit kitchen before swallowing two 200mg Advil Liqui-Gels and sighing in relief. Tracking data suggests the sequence is currently testing higher than any post-credits tag in the studio's history, scoring exceptionally well with key demographic quadrants who just processed two hours of multiverse exposition.
We realized our core demographic is leaving the multiplex with a profound, localized throbbing behind their eyes, and we wanted a brand integration that speaks to their immediate reality.
The pact with the pharmaceutical brand reportedly came together after internal analytics revealed that setting up seven unresolved plot threads per film was actively cannibalizing box office returns. WME, which reps the commercial's primary headache sufferer, is currently fielding offers to lock the actor into a multi-picture deal to swallow pain relievers at the end of Thunderbolts and Avengers: Secret Wars.
Industry insiders note the shift could signal a wider trend for aging intellectual property. At press time, rival studio Warner Bros. had reportedly scrapped a sprawling teaser at the end of its next DC reboot in favor of a quiet, dimly lit screen featuring a slow push-in on a bottle of Pepto Bismol.